Piperidine and piperazine acetamide derivatives

Details Piperidine and piperazine acetamide derivatives Piperidine and piperazine acetamide derivatives

2005-11-29

2005-11-29

McKenzie, Thomas C. (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C514S249000, C514S252120, C514S252140, C514S252160, C514S252170, C514S253010, C514S253070, C514S254010, C514S254040, C514S254050, C514S255030, C514S255050, C514S316000, C514S317000, C514S330000, C514S331000, C544S121000, C544S253000, C544S255000, C544S277000, C544S349000, C544S356000, C544S357000, C544S360000, C544S363000, C544S369000, C544S370000, C544S371000, C544S372000, C544S393000, C546S189000, C546S234000

Reexamination Certificate

active

06969713

ABSTRACT:
The invention provides piperidine and piperazine derivatives of general formula (I), processes for their preparation, pharmaceutical compositions containing them, a process for preparing the pharmaceutical compositions, and their use in therapy

REFERENCES:
patent: 3029241 (1962-04-01), Fancher et al.
patent: 6201024 (2001-03-01), Baxter et al.
patent: 6242470 (2001-06-01), Baxter et al.
patent: 6258838 (2001-07-01), Baxter et al.
patent: 6303659 (2001-10-01), Baxter et al.
patent: 6492355 (2002-12-01), Alcaraz et al.
patent: 6555541 (2003-04-01), Furber et al.
patent: 6720452 (2004-04-01), Alcaraz et al.
patent: 6812226 (2004-11-01), Baxter et al.
patent: 0074768 (1983-03-01), None
patent: 0582164 (1994-02-01), None
patent: 2346011 (1977-10-01), None
patent: WO 97/47601 (1997-12-01), None
patent: WO 99/31096 (1999-06-01), None
patent: WO 99/59582 (1999-11-01), None
patent: 01/44170 (2001-06-01), None
West, Anthony R., Solid State Chemistry and its Applications, Wiley, New York, 1988, pp. 358 & 365.
Vera Ralevica and Geoffrey Burnstock, Pharmacological Reviews, vol. 50, Issue 3, 413-492, Sep. 1998.
R. Alan North , Physiol. Rev. 82: 1013-1067, 2002.
Chemical Abstracts, vol. 84, No. 9, Mar. 1, 1976, p. 527, The Abstract No. 59466u, JP 75108264A (Maruyama, Isamu et al.) Aug. 26, 1975.
Chemical Abstracts, vol. 57 (1962), Shin Hayao et al., “New sedative and hypotensive phenylpiperazine amides”, The Abstract No. 3443i, J. Org. Chem. 1961, 26, 3414-3419.
STN International, File Caplus, Caplus accession No. 1995:324637, Document No. 122:105919, Kyowa Hakko Kogyo KK: Preparation of quinazolinylpiperazineacetamide derivatives; & JP A2, 06247942, 19940906.
STN International, File Caplus, Caplus accession No. 1991:656226, Document No. 115:256226, Kowa K.K., “Preparation of piperazine derivatives as antiarrhythmics”, & JP, A2, 19910617.
Ferrari et al., “Purinergic Modulation of Interleukin-1β Release from Microglial Cells Stimulated with Bacterial Endotoxin”, J. Exp. Med., 185 (3),. 1997, pp. 579-582.
Ferrari et al., “Extracellular ATP Triggers IL-1β Release by Activating the Purinergic P2Z Receptor of Human Macrophages”, Journal of Immunology, 1997, 159(3), pp. 1451-1458.
Yu et al., “Inhibition of IL-1 Release from Hunan Monocytes and Suppression of Streptococcal Cell Wall and Adjuvant-induced Arthritis in Rats by an Extract ofTripterygium wilfordiiHook”, General Pharmacology, 1994, 25(6), pp. 1115-1122.
Otterness et al., “Possible Role of IL-1 in Arthritis: Effects of Prostaglandins in the Regulation of IL-1 Synthesis and Actions”, Joint Destruction in Arthritis and Osteoarthritis, Agents and Actions Supplements, 1993, 39, pp. 109-120.
Henderson et al., “Inhibition of Interleukin-1-Induced Synovitis and Articular Cartilage Proteoglycan Loss in the Rabbit Knee by Recombinant Human Interleukin-1 Receptor Antagonist”, Cytokine, 3(3), 1991, pp. 246-249.
Kodata et al., “Significance of IL-1β and IL-1 receptor antagonist (IL-1Ra) in bronchoalveolar lavage fluid (BALF) in patients with diffuse panbronchiolitis (DPB)”, Clin Exp Immunol, 1996, 103, pp. 461-466.
Sakito et al., “Interleukin 1β, Tumor Necrosis Factor Alpha, and Interleukin 8 in Bronchoalveolar Lavage Fluid of Patients with Diffuse Panbronchiolitis: A Potential Mechanism of Macrolide Therapy”, Respiration, 63, pp. 42-48.

Affiliated with

Also associated with

Rating

Piperidine and piperazine acetamide derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Piperidine and piperazine acetamide derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Piperidine and piperazine acetamide derivatives will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3493048